High throughput screening (HTS) is majorly used by pharmaceuticals, biotech and academic institutes for drug discovery, target validation and the identification of genes or proteins that modulate a particular biological pathway. High-throughput screening provides efficient measurement of the effects of agents or conditions in biological or chemical assays.

The market of high throughput screening is anticipated to grow with a significant rate in the coming years, owing to factors such as, growth in adoption of globalized innovative models in pharmaceutical and biotechnology companies, increasing investment in research and development, and technological advancement. Moreover, rising prevalence of a number of diseases, and increase in government funding and venture capital investments are also expected to propel the growth of this market. On other hand the rapid growth in emerging countries and growing R&D activities on toxicology and stem cells is expected to offer growth opportunities for the players operating in the high throughput screening market.

The "Global High Throughput Screening Market Analysis to 2025" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global high throughput screening market with detailed market segmentation by product, technology, application, end user, and geography. The global high throughput screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global high throughput screening market is segmented on the basis of product, technology, application, end user, and geography. The product segment includes, consumables & accessories, reagents & assay kits, services, software, and instruments. On the basis of technology, the high throughput screening market is segmented into cell-based assays, bioinformatics, lab-on-a-chip, label-free technology, and ultra-high-throughput screening. The segment of cell-based assays is further classified into perfusion cell culture, 2D cell culture, and 3D cell culture. On the basis of 3D cell culture, the high throughput screening market is segmented as, scaffold-based technology, and scaffold-free technology. Based on application, the market is segmented into primary and secondary screening, target identification and validation, toxicology assessment, and other applications. Based on end user, the market is classified as, pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and government institutes, and other end users.

The high throughput screening market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global high throughput screening market based on product, technology, and application, and end user. It also provides market size and forecast till 2025 for overall high throughput screening market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The high throughput screening market market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America hold the largest market share of the high throughput screening market, owing to the well developed and established healthcare industry, increased awareness, presence of government initiatives and funding, and easy accessibility to advanced technologies in the region. On the other hand, the Asia-Pacific region is expected to grow at a significant rate during the forecast period. The highest growth in the region is attributed to the increasing research and development activities, and growing demand for better quality medical care in countries such as Japan, China, and India.

The high throughput screening report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The high throughput screening market report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The high throughput screening report also includes the profiles of key high throughput screening manufacturing companies along with their SWOT analysis and market strategies. In addition, the high throughput screening market report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Danaher, PerkinElmer Inc., Axxam S.p.A., Tecan Trading AG, Bio-Rad Laboratories, Inc., Corning Incorporated, Aurora Biomed Inc., and Merck KGaA among others.